Joy Faucher
General Partner @ Forbion Capital Partners
Naarden, The Netherlands
Joy Faucher is a Series A investor at Forbion Capital Partners in Naarden focused on Biotechnology and Farming. Joy Faucher is based out of Naarden, Noord-Holland and is the General Partner at Forbion Capital Partners. He graduated from the University of Cambridge.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Joy Faucher invests in
Stages Joy Faucher invests in
Countries Joy Faucher invests in
Investment Focus
Industry
- Biotechnology 4 (100%)
- Farming 1 (25%)
- Agriculture 1 (25%)
- Sustainability 1 (25%)
- Food and Beverage 1 (25%)
Stage
- Series A 2 (50%)
- Pre-Seed 1 (25%)
- Series C 1 (25%)
Country
- United Kingdom 3 (75%)
- The Netherlands 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tropic Biosciences
|
At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. | $105M / Series C / Mar 12, 2026 | |
PACT
|
PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals. | $21.1M / Series A / Oct 30, 2025 | |
Solasta Bio
|
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection. | $14M / Series A / Sep 11, 2024 | |
Farmless
|
A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks. | $1.3M / Pre-Seed / May 10, 2023 |
Co-Investors
Scottish Enterprise
2 deals together
Genoa Ventures
1 deal together
Aliment Capital
1 deal together
Cavallo Ventures
1 deal together
Corteva Agriscience
1 deal together
Corteva Catalyst
1 deal together
About Forbion Capital Partners
Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine investment professionals has built an impressive performance track record since the late nineties with successfulinvestments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.
Forbion Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Joy Faucher
General Partner
|
|||
Marco Boorsma
General Partner
|
|||
Nanna Lüneborg
General Partner
|
|||
Onno Stolpe
Venture Partner
|
|||
Sander Slootweg
Managing Partner and co-founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Joy Faucher invest in?
Joy Faucher invests primarily in Biotechnology, Farming and Agriculture startups, most often at Series A and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Joy Faucher last invest?
The most recent investment recorded for Joy Faucher closed in Mar 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
